Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Curr Alzheimer Res

Retrieve available abstracts of 150 articles:
HTML format
Text format



Single Articles


    October 2018
  1. HAMANO T, Hayashi K, Shirafuji N, Nakamoto Y, et al
    The Implications of Autophagy in Alzheimer's disease.
    Curr Alzheimer Res. 2018 Oct 4. pii: CAR-EPUB-93438.
    PubMed     Text format     Abstract available


  2. KUTOVA M, Mrzilkova J, Riedlova J, Zach P, et al
    Asymmetric changes in limbic cortex and planum temporale in patients with Alzheimer disease.
    Curr Alzheimer Res. 2018 Oct 4. pii: CAR-EPUB-93436.
    PubMed     Text format     Abstract available


  3. CHOU PS, Kao YH, Wu MN, Chou MC, et al
    Effect of the interaction between hypertension and cerebral white matter changes on the progression of Alzheimer disease.
    Curr Alzheimer Res. 2018 Oct 2. pii: CAR-EPUB-93369.
    PubMed     Text format     Abstract available


  4. KLIMOVA B, Maresova P, Kuca K
    Alzheimer's Disease: Physical Activities as an Effective Intervention Tool - A Mini-Review.
    Curr Alzheimer Res. 2018 Oct 2. pii: CAR-EPUB-93366.
    PubMed     Text format     Abstract available


    September 2018
  5. KLIMOVA B, Kuca K, Maresova P
    Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment.
    Curr Alzheimer Res. 2018 Sep 25. pii: CAR-EPUB-93206.
    PubMed     Text format     Abstract available


  6. KLIMOVA B, Maresova P, Kuca K
    Alzheimer's Disease: Special Focus on the Efficacy of Computer-Based Training Programs - A Mini-Review.
    Curr Alzheimer Res. 2018 Sep 24. pii: CAR-EPUB-93205.
    PubMed     Text format     Abstract available


  7. REESINK FE, Garcia DV, Sanchez-Catasus CA, Peretti DE, et al
    Crossed Cerebellar Diaschisis in Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Sep 12. pii: CAR-EPUB-93027.
    PubMed     Text format     Abstract available


  8. JAHNG GH, Choi W, Chung JJ, Kim ST, et al
    Mapping Exchangeable Protons to Monitor Protein Alterations in the Brain of an Alzheimer's Disease Mouse Model by using MRI.
    Curr Alzheimer Res. 2018 Sep 11. pii: CAR-EPUB-92973.
    PubMed     Text format     Abstract available


  9. LEKO MB, Skoric MK, Klepac N, Borovecki F, et al
    Event-related potentials improve the efficiency of cerebrospinal fluid biomarkers for differential diagnosis of Alzheimer's disease.
    Curr Alzheimer Res. 2018 Sep 11. pii: CAR-EPUB-92976.
    PubMed     Text format     Abstract available


  10. PENKE B, Paragi G, Gera J, Berkecz R, et al
    The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View.
    Curr Alzheimer Res. 2018 Sep 11. pii: CAR-EPUB-92977.
    PubMed     Text format     Abstract available


  11. WILSON EN, Carmo SD, Iulita MF, Hall H, et al
    Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and Neuroinflammation in a Rat Model of Alzheimer's-like Amyloidosis.
    Curr Alzheimer Res. 2018 Sep 4. pii: CAR-EPUB-92816.
    PubMed     Text format     Abstract available


  12. JUNGES VM, Closs VE, Nogueira GM, Gottlieb MGV, et al
    Crosstalk Between Gut Microbiota and the Central Nervous System: A Focus for Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Sep 4. pii: CAR-EPUB-92817.
    PubMed     Text format     Abstract available


  13. ZHAI R, Rizak J, Zheng N, He X, et al
    Alzheimer's Disease-Like Pathologies and Cognitive Impairments Induced by Formaldehyde in Nonhuman Primates.
    Curr Alzheimer Res. 2018 Sep 4. pii: CAR-EPUB-92815.
    PubMed     Text format     Abstract available


    August 2018
  14. MARESOVA P, Kuca K
    Missing uniform costs classification for Alzheimer's disease treatment and care.
    Curr Alzheimer Res. 2018 Aug 30. pii: CAR-EPUB-92726.
    PubMed     Text format     Abstract available


  15. SALLOWAY S, Marshall GA, Lu M, Brashear HR, et al
    Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-To-Moderate Alzheimer's Disease: A Phase 2, Open Label Extension Study.
    Curr Alzheimer Res. 2018 Aug 20. pii: CAR-EPUB-92549.
    PubMed     Text format     Abstract available


  16. VEGA IE, Umstead A, Wygant CM, Beck JS, et al
    Ezrin expression is increased during disease progression in a tauopathy mouse model and Alzheimer's disease.
    Curr Alzheimer Res. 2018 Aug 13. pii: CAR-EPUB-92381.
    PubMed     Text format     Abstract available


  17. DE CASTRO AA, da Cunha EFF, Pereira AF, Soares FV, et al
    Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives.
    Curr Alzheimer Res. 2018 Aug 13. pii: CAR-EPUB-92380.
    PubMed     Text format     Abstract available


  18. JIANG Z, Yang H, Tang X
    Deformation-based Statistical Shape Analysis of the Corpus Callosum in Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Aug 13. pii: CAR-EPUB-92379.
    PubMed     Text format     Abstract available


  19. GONZALEZ-NOSTI M, Cuetos F, Martnez C
    Oral And Written Naming In Alzheimer's Disease: A Longitudinal Study.
    Curr Alzheimer Res. 2018 Aug 13. pii: CAR-EPUB-92378.
    PubMed     Text format     Abstract available


  20. LEBLHUBER F, Steiner K, Schuetz B, Fuchs D, et al
    Probiotic Supplementation in Patients with Alzheimer's Dementia - An Explorative Intervention Study.
    Curr Alzheimer Res. 2018 Aug 13. pii: CAR-EPUB-92377.
    PubMed     Text format     Abstract available


    July 2018
  21. COMBS C, Manocha G, Ghatak A, Puig K, et al
    Anti-alpha4beta1 integrin antibodies attenuated brain inflammatory changes in a mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2018 Jul 31. pii: CAR-EPUB-92096.
    PubMed     Text format     Abstract available


  22. BIHAQI SW, Alansi B, Masoud AM, Mushtaq F, et al
    Influence of Early Life Lead (Pb) exposure on alpha-Synuclein, GSK-3beta and Caspase-3 mediated Tauopathy: Implications on Alzheimer's disease.
    Curr Alzheimer Res. 2018 Jul 31. pii: CAR-EPUB-92092.
    PubMed     Text format     Abstract available


  23. KAPOGIANNIS D, El Haj M
    Beneficial effect of minimal interference on item memory but not on source memory in Alzheimer's disease.
    Curr Alzheimer Res. 2018 Jul 10. pii: CAR-EPUB-91624.
    PubMed     Text format     Abstract available


  24. LAZZARI C
    Ecological Momentary Assessments and Interventions in Alzheimer's Caregiving.
    Curr Alzheimer Res. 2018 Jul 1. pii: CAR-EPUB-91415.
    PubMed     Text format     Abstract available


    June 2018
  25. RUFFINATTI F, Tapella L, Gregnanin I, Stevano A, et al
    Transcriptional remodeling in primary hippocampal astrocytes from an Alzheimer's disease mouse model.
    Curr Alzheimer Res. 2018 Jun 12. pii: CAR-EPUB-91108.
    PubMed     Text format     Abstract available


  26. BLESA R, Toriyama K, Ueda K, Knox S, et al
    Strategies for Continued Successful Treatment in Patients with Alzheimer's Disease: An Overview of Switching Between Pharmacological Agents.
    Curr Alzheimer Res. 2018 Jun 12. pii: CAR-EPUB-91107.
    PubMed     Text format     Abstract available


  27. WEE M, Chegini F, Power JHT, Majd S, et al
    Tau Positive Neurons Show Marked Mitochondrial Loss and Nuclear Degradation in Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Jun 12. pii: CAR-EPUB-91110.
    PubMed     Text format     Abstract available


  28. EZIO G, Giancarlo P
    Sex and Gender Differences in the Brain Cholinergic System and in the Response to Therapy of Alzheimer Disease with Cholinesterase Inhibitors.
    Curr Alzheimer Res. 2018 Jun 12. pii: CAR-EPUB-91106.
    PubMed     Text format     Abstract available


    May 2018
  29. ZVEROVA M, Kitzlerova E, Fisar Z, Jirak R, et al
    Interplay between the APOE genotype and possible plasma biomarkers in Alzheimer's disease.
    Curr Alzheimer Res. 2018 May 31. pii: CAR-EPUB-90848.
    PubMed     Text format     Abstract available


  30. WAN L, Lu J, Fu J, Huang J, et al
    Acetylcholinesterase inhibitor donepezil effects on plasma beta-hydroxybutyrate levels in the treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2018 May 31. pii: CAR-EPUB-90849.
    PubMed     Text format     Abstract available


  31. WATTMO C, Londos E, Minthon L
    Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.
    Curr Alzheimer Res. 2018 May 6. pii: CAR-EPUB-90210.
    PubMed     Text format     Abstract available


    April 2018
  32. RUAN Y, Tang J, Guo X, Li K, et al
    Dietary Fat Intake and Risk of Alzheimer's Disease and Dementia: A Meta-Analysis of Cohort Studies.
    Curr Alzheimer Res. 2018 Apr 27. pii: CAR-EPUB-90033.
    PubMed     Text format     Abstract available


  33. MARESOVA P, Tomsone S, Lameski P, Madureira J, et al
    Technological Solutions for Older People with Alzheimer's Disease: Review.
    Curr Alzheimer Res. 2018 Apr 27. pii: CAR-EPUB-90032.
    PubMed     Text format     Abstract available


  34. PATTEN RV, Fagan AM, Kaufman DAS
    Differential Cued-Stroop Performance in Cognitively Asymptomatic Older Adults with Biomarker-Identified Risk for Alzheimer's Disease: A Pilot Study.
    Curr Alzheimer Res. 2018 Apr 4. pii: CAR-EPUB-89533.
    PubMed     Text format     Abstract available


  35. MUKAETOVA-LADINSKA EB, Abdell-All Z, Andrade J, da Silva JA, et al
    Platelet tau protein as a potential peripheral biomarker in Alzheimer's disease: An explorative study.
    Curr Alzheimer Res. 2018 Apr 4. pii: CAR-EPUB-89532.
    PubMed     Text format     Abstract available


  36. DE LOOZE C, Kelly F, Crosby L, Vourdanou A, et al
    Changes in Speech Chunking in Reading Aloud is a marker of Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Apr 4. pii: CAR-EPUB-89531.
    PubMed     Text format     Abstract available


  37. LIU SY, Lu S, Yu XL, Yang SG, et al
    Fruitless wolfberry-sprout extract rescued cognitive deficits and attenuated neuropathology in Alzheimer's disease transgenic mice.
    Curr Alzheimer Res. 2018 Apr 4. pii: CAR-EPUB-89527.
    PubMed     Text format     Abstract available


  38. BATURE F, Pang D, Robinson A, Polson N, et al
    Identifying patterns in signs and symptoms preceding the clinical diagnosis of Alzheimer's disease: Retrospective medical record review study and a nested case -control design.
    Curr Alzheimer Res. 2018 Apr 4. pii: CAR-EPUB-89525.
    PubMed     Text format     Abstract available


    February 2018
  39. MAJD S, Power JHT
    Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxin 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer's disease.
    Curr Alzheimer Res. 2018 Feb 22. pii: CAR-EPUB-88760.
    PubMed     Text format     Abstract available


  40. MORENO S
    Editorial: Signaling Molecules as Biomarkers and Therapeutic Targets for Alzheimer's Disease: A New Perspective.
    Curr Alzheimer Res. 2018;15:302.
    PubMed     Text format    


  41. MARTINEZ-TORTEYA A, Gomez-Rueda H, Trevino V, Farber J, et al
    Identification and Temporal Characterization of Features Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Feb 1. pii: CAR-EPUB-88334.
    PubMed     Text format     Abstract available


    January 2018
  42. UKALOVIC K, Cao S, Lee S, Tang Q, et al
    Drusen in the Peripheral Retina of the Alzheimer's Eye.
    Curr Alzheimer Res. 2018 Jan 23. pii: CAR-EPUB-88136.
    PubMed     Text format     Abstract available


  43. SANCESARIO GM, Nuccetelli M, Cerri A, Zegeer J, et al
    Bromelain degrades Abeta1-42 monomers and soluble aggregates: an in vitro study in cerebrospinal fluid of Alzheimer's disease patients.
    Curr Alzheimer Res. 2018 Jan 23. pii: CAR-EPUB-88138.
    PubMed     Text format     Abstract available


  44. MORRISON C, Rabipour S, Knoefel F, Shepard C, et al
    Auditory Event-Related Potentials in Mild Cognitive Impairment and Alzheimer's disease: A Literature Review.
    Curr Alzheimer Res. 2018 Jan 23. pii: CAR-EPUB-88137.
    PubMed     Text format     Abstract available


  45. DAVIS M, O Connell T, Johnson S, Cline S, et al
    Estimating Alzheimer's disease progression rates from normal cognition through mild cognitive impairment and stages of dementia.
    Curr Alzheimer Res. 2018 Jan 18. pii: CAR-EPUB-88040.
    PubMed     Text format     Abstract available


  46. ZHANG H, Liu D, Huang H, Zhao Y, et al
    Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-analysis.
    Curr Alzheimer Res. 2018 Jan 18. pii: CAR-EPUB-88046.
    PubMed     Text format     Abstract available


  47. BECKER RE, Greig NH, Lahiri DK, Bledsoe J, et al
    (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Jan 10. pii: CAR-EPUB-87805.
    PubMed     Text format     Abstract available


  48. VERCRUYSSE O, Paquet C, Gabelle A, Delbeuck X, et al
    Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF biomarkers.
    Curr Alzheimer Res. 2018 Jan 9. pii: CAR-EPUB-87803.
    PubMed     Text format     Abstract available


    December 2017
  49. KUCHTOVA B, Wurst Z, Mrzilkova J, Ibrahim I, et al
    Compensatory shift of subcallosal area and paraterminal gyrus white matter parameters on DTI in patients with Alzheimer disease.
    Curr Alzheimer Res. 2017 Dec 27. pii: CAR-EPUB-87574.
    PubMed     Text format     Abstract available


  50. SANZ-BLASCO S, Calvo-Rodriguez M, Caballero E, Garcia-Durillo M, et al
    Is it all said for NSAIDs in Alzheimer's disease? Role of mitochondrial calcium uptake.
    Curr Alzheimer Res. 2017 Dec 27. pii: CAR-EPUB-87572.
    PubMed     Text format     Abstract available


  51. PERKOVIC MN, Strac DS, Tudor L, Konjevod M, et al
    Catechol-O-methyltransferase, cognition and Alzheimer's disease.
    Curr Alzheimer Res. 2017 Dec 11. pii: CAR-EPUB-87350.
    PubMed     Text format     Abstract available


    November 2017
  52. LOPEZ-DE-IPINA K, Martinez-de-Lizarduy U, Calvo PM, Mekyska J, et al
    Advances on Automatic Speech Analysis for Early Detection of Alzheimer Disease: a Non-linear Multi-task Approach.
    Curr Alzheimer Res. 2017 Nov 20. doi: 10.2174/1567205014666171120143800.
    PubMed     Text format     Abstract available


  53. JIRI C, Ross A, Jan L, Martin V, et al
    Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Nov 20. doi: 10.2174/1567205014666171120145349.
    PubMed     Text format     Abstract available


  54. KATO S, Homma A, Sakuma T
    Easy Screening for Mild Alzheimer's Disease and Mild Cognitive Impairment from Elderly Speech.
    Curr Alzheimer Res. 2017 Nov 20. doi: 10.2174/1567205014666171120144343.
    PubMed     Text format     Abstract available


  55. TREBBASTONI A, Imbriano L, Podda L, Rendace L, et al
    Cognitive training in patients with Alzheimer's disease: findings of a 12-month randomized controlled trial.
    Curr Alzheimer Res. 2017 Nov 12. doi: 10.2174/1567205014666171113105044.
    PubMed     Text format     Abstract available


  56. QIU WY, Yang Q, Zhang W, Wang N, et al
    The Correlations Between Postmortem Brain Pathologies and Cognitive Dysfunction in Aging and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Nov 6. doi: 10.2174/1567205014666171106150915.
    PubMed     Text format     Abstract available


  57. VERMA N, Beretvas SN, Pascual B, Masdeu JC, et al
    A biomarker combining imaging and neuropsychological assessment for tracking early Alzheimer's disease in clinical trials.
    Curr Alzheimer Res. 2017 Nov 6. doi: 10.2174/1567205014666171106150309.
    PubMed     Text format     Abstract available


    October 2017
  58. RUGGIERO G, Iavarone A, Iachini T
    Allocentric to Egocentric Spatial Switching: Impairment in aMCI and Alzheimer's Disease Patients?
    Curr Alzheimer Res. 2017 Oct 30. doi: 10.2174/1567205014666171030114821.
    PubMed     Text format     Abstract available


  59. XAVIER C, Justine B, Laurent O, Isabelle L, et al
    Body-centred and object-centred motor imagery in Alzheimer disease.
    Curr Alzheimer Res. 2017 Oct 29. doi: 10.2174/1567205014666171030105720.
    PubMed     Text format     Abstract available


  60. DE OLIVEIRA FF, Chen ES, Smith MC, Bertolucci PHF, et al
    Pharmacogenetics of angiotensin-converting enzyme inhibitors in patients with Alzheimer's disease dementia.
    Curr Alzheimer Res. 2017 Oct 16. doi: 10.2174/1567205014666171016101816.
    PubMed     Text format     Abstract available


  61. SUNG PS, Wu MN, Chou PS, Su HC, et al
    Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease patients treated with medication.
    Curr Alzheimer Res. 2017 Oct 10. doi: 10.2174/1567205014666171010112518.
    PubMed     Text format     Abstract available


    September 2017
  62. MANYEVITCH R, Protas M, Scarpiello S, Deliso M, et al
    Evaluation Of Metabolic And Synaptic Dysfunction Hypotheses Of Alzheimer's Disease (Ad): A Meta-Analysis Of Csf Markers.
    Curr Alzheimer Res. 2017 Sep 21. doi: 10.2174/1567205014666170921122458.
    PubMed     Text format     Abstract available


  63. ORTIZ A, Lozano F, Gorriz JM, Ramirez J, et al
    Discriminative Sparse Features for Alzheimer's Disease Diagnosis using multimodal image data.
    Curr Alzheimer Res. 2017 Sep 21. doi: 10.2174/1567205014666170922101135.
    PubMed     Text format     Abstract available


  64. ERDMANN P, Langanke M
    The Ambivalence of Early Diagnosis - Returning results in current Alzheimer research.
    Curr Alzheimer Res. 2017 Sep 7. doi: 10.2174/1567205014666170908101237.
    PubMed     Text format     Abstract available


    August 2017
  65. BUSINARO R, Di Raimo T, Corsi M, Asprino R, et al
    Modulation Of Inflammation As A Way Of Delaying Alzheimer's Disease Progression: The Diet's Role.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829100100.
    PubMed     Text format     Abstract available


  66. GUPTA P, Bhattacharjee S, Sharma AR, Sharma G, et al
    miRNAs in Alzheimer disease - a Therapeutic perspective.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829101016.
    PubMed     Text format     Abstract available


  67. QIAN W, Fischer CE, Schweizer TA, Munoz DG, et al
    Association between psychosis phenotype and APOE genotype on the clinical profiles of Alzheimer's disease.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829114346.
    PubMed     Text format     Abstract available


  68. MEILAN JJG, Martinez-Sanchez F, Carro J, Carcavilla N, et al
    Voice Markers of Lexical Access in Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829112439.
    PubMed     Text format     Abstract available


  69. LO VASCO VR
    The Phosphoinositide signal transduction pathway in the pathogenesis of Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829100230.
    PubMed     Text format     Abstract available


    July 2017
  70. LI N, Hu P, Xu T, Chen H, et al
    iTRAQ-based proteomic analysis of APPSw,Ind mice provides insights into the early changes in Alzheimer's disease.
    Curr Alzheimer Res. 2017 Jul 19. doi: 10.2174/1567205014666170719165745.
    PubMed     Text format     Abstract available


  71. FUKASAWA JT, Labio RW, Rasmussen LT, Oliveira LC, et al
    CDK5 and MAPT Gene Expression in Alzheimer's Disease Brain Samples.
    Curr Alzheimer Res. 2017 Jul 13. doi: 10.2174/1567205014666170713160407.
    PubMed     Text format     Abstract available


  72. ARENA A, Iyer AM, Milenkovic I, Kovacs GG, et al
    Developmental expression and dysregulation of miR-146a and miR-155 in Down's syndrome and mouse models of Down's syndrome and Alzheimer's disease.
    Curr Alzheimer Res. 2017 Jul 6. doi: 10.2174/1567205014666170706112701.
    PubMed     Text format     Abstract available


    June 2017
  73. SQUITT R, Simonelli I, Cassetta E, Lupoi D, et al
    Patients with increased non-ceruloplasmin copper appear a distinct sub-group of alzheimer's disease: a neuroimaging study.
    Curr Alzheimer Res. 2017 Jun 23. doi: 10.2174/1567205014666170623125156.
    PubMed     Text format     Abstract available


  74. KOLOSOVA NG, Tyumentsev MA, Muraleva NA, Kiseleva E, et al
    Antioxidant SkQ1 Alleviates Signs of Alzheimer's Disease-like Pathology in Old OXYS Rats by Reversing Mitochondrial Deterioration.
    Curr Alzheimer Res. 2017 Jun 21. doi: 10.2174/1567205014666170621111033.
    PubMed     Text format     Abstract available


  75. PARRA MA, Mikulan E, Trujillo N, Sala SD, et al
    Brain information sharing during visual short-term memory binding yields a memory biomarker for familial Alzheimer's disease.
    Curr Alzheimer Res. 2017 Jun 14. doi: 10.2174/1567205014666170614163316.
    PubMed     Text format     Abstract available


    May 2017
  76. SILVA AR, Pinho MS, Macedo L, Moulin CJA, et al
    The cognitive effects of wearable cameras in Mild Alzheimer disease - An experimental study.
    Curr Alzheimer Res. 2017 May 30. doi: 10.2174/1567205014666170531083015.
    PubMed     Text format     Abstract available


  77. WAMS EJ, Wilcock GK, Foster RG, Wulff K, et al
    Sleep-wake patterns and cognition of older adults with amnestic mild cognitive impairment (aMCI): A comparison with cognitively healthy adults and moderate Alzheimer's disease patients.
    Curr Alzheimer Res. 2017 May 22. doi: 10.2174/1567205014666170523095634.
    PubMed     Text format     Abstract available


  78. AHMAD J, Akhter S, Rizwanullah M, Khan MA, et al
    Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.
    Curr Alzheimer Res. 2017 May 8. doi: 10.2174/1567205014666170508121031.
    PubMed     Text format     Abstract available


  79. D ORIO B, Fracassi A, Ceru MP, Moreno S, et al
    Targeting Pparalpha In Alzheimer`s Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505094549.
    PubMed     Text format     Abstract available


  80. MARCELLI S, Corbo M, Iannuzzi F, Negri L, et al
    The Involvement of Post-Translational Modifications in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505095109.
    PubMed     Text format     Abstract available


  81. ZARROUK A, Debbabi M, Bezine M, Karym EM, et al
    Lipid Biomarkers in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505101426.
    PubMed     Text format     Abstract available


  82. ARMAND-UGON M, Ansoleaga B, Berjaoui S, Ferrer I, et al
    Reduced mitochondrial activity is early and steady in the entorhinal cortex but it is mainly unmodified in the frontal cortex in Alzheimer's disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505095921.
    PubMed     Text format     Abstract available


    April 2017
  83. ALAMEDA-BAILEN JR, Salguero-Alcaniz MP, Merchan-Clavellino A, Paino-Quesada S, et al
    Cognitive Mechanisms In Decision-Making In Patients With Mild Alzheimer Disease.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417113834.
    PubMed     Text format     Abstract available


  84. HE J, Liao T, Zhong GX, Zhang JD, et al
    Alzheimer`s disease-like early-phase brain pathogenesis: Self-curing amelioration of neurodegeneration from pro-inflammatory 'wounding' to anti-inflammatory 'healing'.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417111420.
    PubMed     Text format     Abstract available


  85. GAO Y, Tan L, Yu JT, Tan L, et al
    Tau in Alzheimer's disease: Mechanisms and therapeutic strategies.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417111859.
    PubMed     Text format     Abstract available


  86. KOJIMA G, Liljas A, Iliffe S, Walters K, et al
    Prevalence of Frailty in Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-analysis.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417104236.
    PubMed     Text format     Abstract available


  87. VERITE J, Janet T, Julian A, Chassaing D, et al
    Peripheral blood mononuclear cells of Alzheimer's disease patients control CCL4 and CXCL10 levels in a human blood brain barrier model.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417110337.
    PubMed     Text format     Abstract available


    March 2017
  88. SHARIFLOU S, Georgevsky D, Mansour H, Rezaeian M, et al
    Diagnostic and prognostic potential of retinal biomarkers in early on-set Alzheimer`s disease.
    Curr Alzheimer Res. 2017 Mar 29. doi: 10.2174/1567205014666170329114445.
    PubMed     Text format     Abstract available


  89. ECHEVERRIA V, Barreto GE, Avila-Rodriguez M, Tarasov VV, et al
    Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease?
    Curr Alzheimer Res. 2017 Mar 29. doi: 10.2174/1567205014666170329113007.
    PubMed     Text format     Abstract available


  90. DOMINGUES C, da Cruz E Silva OA, Henriques AG
    Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks.
    Curr Alzheimer Res. 2017 Mar 17. doi: 10.2174/1567205014666170317113606.
    PubMed     Text format     Abstract available


  91. RODRIGUEZ-CASADO A, Toledano-Diaz A, Toledano A
    Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions.
    Curr Alzheimer Res. 2017 Mar 16. doi: 10.2174/1567205014666170316161848.
    PubMed     Text format     Abstract available


  92. POZA J, Gomez C, Garcia M, Tola-Arribas MA, et al
    Spatio-Temporal Fluctuations of Neural Dynamics in Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309115656.
    PubMed     Text format     Abstract available


  93. GARRE-OLMO J, Faundez-Zanuy M, Lopez-de-Ipina K, Calvo-Perxas L, et al
    Kinematic and pressure features of handwriting and drawing: preliminary results between patients with mild cognitive impairment, Alzheimer disease and healthy controls.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309120708.
    PubMed     Text format     Abstract available


  94. GARRARD P, Nemes V, Nikolic D, Barney A, et al
    Motif discovery in speech: Application to monitoring Alzheimer's disease.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309121025.
    PubMed     Text format     Abstract available


    February 2017
  95. SHARMA S, Lipincott W
    Biomarkers in Alzheimer's Disease-Recent Update.
    Curr Alzheimer Res. 2017 Feb 20. doi: 10.2174/1567205014666170220141822.
    PubMed     Text format     Abstract available


  96. KIM J, Fischer CE, Schweizer TA, Munoz DG, et al
    Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Feb 20. doi: 10.2174/1567205014666170220150021.
    PubMed     Text format     Abstract available


  97. NIXON DW
    The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism.
    Curr Alzheimer Res. 2017 Feb 16. doi: 10.2174/1567205014666170216152905.
    PubMed     Text format     Abstract available


  98. DE MARCO M, Vallelunga A, Meneghello F, Varma S, et al
    ApoE epsilon4 allele relateted alterations in hippocampal connectivity in early Alzheimer's disease support memory performance.
    Curr Alzheimer Res. 2017 Feb 6. doi: 10.2174/1567205014666170206113528.
    PubMed     Text format     Abstract available


  99. WU W, Xie S, Li B, Yang K, et al
    Protective effects of Huang-Lian-Jie-Du-Tang on Abeta25-35-induced memory deficits and oxidative stress in male rats.
    Curr Alzheimer Res. 2017 Feb 6. doi: 10.2174/1567205014666170206163158.
    PubMed     Text format     Abstract available


  100. NICOLIA V, Ciraci V, Cavallaro RA, Ferrer I, et al
    GSK3beta 5'-flanking DNA methylation and expression in Alzheimer's Disease patients.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203153325.
    PubMed     Text format     Abstract available


  101. LESZEK J, Tse WH, Zhang J, Avila-Rodriguez MF, et al
    Nanotechnology for Alzheimer Disease.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203125008.
    PubMed     Text format     Abstract available


  102. MANTZAVINOSA V, Alexiou A, Greig NH, Kamal MA, et al
    Biomarkers for Alzheimer's Disease Diagnosis.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203125942.
    PubMed     Text format     Abstract available


  103. AHMAD K, Baig MH, Mushtaq G, Kamal MA, et al
    Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer Disease and other neurodegenerative diseases: An in silico-updated overview.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203141151.
    PubMed     Text format     Abstract available


  104. REGEN F, Hellmann-Regen J, Costantini E, Reale M, et al
    Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203141717.
    PubMed     Text format     Abstract available


  105. SHACKLETON B, Crawford F, Bachmeier C
    Apolipoprotein E-mediated modulation of ADAM10 in Alzheimer's disease.
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203093219.
    PubMed     Text format     Abstract available


  106. CHHETRI J, King AE, Gueven N
    Alzheimer's Disease and NQO1: Is there a Link?
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203095802.
    PubMed     Text format     Abstract available


  107. COSTA IB, Labio RW, Rasmussen LT, Viani GA, et al
    Change in INSR, APBA2 and IDE Gene Expressions in Brains of Alzheimer s Disease Patients.
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203100734.
    PubMed     Text format     Abstract available


    January 2017
  108. DECOURT B, Drumm-Gurnee D, Wilson J, Jacobson S, et al
    Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's disease: Results from a Double-Blind, Placebo-Controlled Trial.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  109. FUKAMI Y, Ariga T, Yamada M, Yuki N, et al
    Brain gangliosides in Alzheimer's disease: Increased expression of cholinergic neuron-specific gangliosides.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  110. HULL M, Sadowsky C, Arai H, Le Prince Leterme G, et al
    Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  111. TERZIOGLU-USAK S, Negis Y, Karabulut DS, Zaim M, et al
    Cellular model of Alzheimer's disease: Abeta1-42 peptide induces amyloid deposition and a decrease in topo isomerase IIbeta and Nurr1 expression.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  112. KLIMOVA B, Kuca K
    Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review Alzheimer's Disease and Chinese Medicine.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  113. ANNA P, Federico S, Massimo V
    Resilience to Alzheimer's disease: the role of physical activity.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  114. KRANTIC S
    Editorial: From Current Diagnostic Tools and Therapeutics for Alzheimer's Disease Towards Earlier Diagnostic Markers and Treatment Targets.
    Curr Alzheimer Res. 2017;14:2-5.
    PubMed     Text format    


  115. LOPEZ-DE-IPINA K, Laske C
    Editorial:Advanced Methods of Biomedical Signal Processing for Early Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2017;14:914-915.
    PubMed     Text format    


  116. SANCHEZ-CATASUS CA, Stormezand GN, van Laar PJ, De Deyn PP, et al
    FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
    Curr Alzheimer Res. 2017;14:127-142.
    PubMed     Text format     Abstract available


  117. KAMAL MA, Greig NH
    Editorial: Alzheimer's Disease: From Molecular Mechanisms to Psychobiological Perspectives.
    Curr Alzheimer Res. 2017;14:1138-1139.
    PubMed     Text format    


  118. PERCHE F, Uchida S, Akiba H, Lin CY, et al
    Improved Brain Expression of Anti-Amyloid beta scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer.
    Curr Alzheimer Res. 2017;14:295-302.
    PubMed     Text format     Abstract available


  119. KNOCHEL C, Voss M, Gruter F, Alves GS, et al
    Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and Dementia.
    Curr Alzheimer Res. 2017;14:240-254.
    PubMed     Text format     Abstract available


  120. ZENG J, Li T, Gong M, Jiang W, et al
    Marginal Vitamin A Deficiency Exacerbates Memory Deficits Following Abeta1-42 Injection in Rats.
    Curr Alzheimer Res. 2017;14:562-570.
    PubMed     Text format     Abstract available


    December 2016
  121. BRUCKMANN S, Brenn A, Grube M, Niedrig K, et al
    Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  122. YU E, Liao Z, Mao D, Zhang Q, et al
    Directed functional connectivity of posterior cingulate cortex and whole brain in Alzheimer's disease and mild cognitive impairment.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  123. PU YZ, Liang L, Fu AL, Liu Y, et al
    Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation under Control of Zebrafish appb Promotor.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    November 2016
  124. MIRZA Z, Beg MA
    Molecular Interactions of Bexarotene - A Retinoid Drug And Alzheimer's Abeta Peptide: A Docking Study.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  125. ZHU R, Liu X, He Z
    Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer's Disease: An Updated Meta-analysis.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  126. ROUCH L, Cestac P, Cool C, Helmer C, et al
    Effectiveness of a standardized and specific follow-up in memory centers in patients with Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  127. IVACHTCHENKO AV, Ivanenkov YA, Veselov MS
    Preclinical evaluation of AVN-322, novel and highly selective 5-HT6 receptor antagonist, for the treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    October 2016
  128. SEIDL C, de Moraes Santos CA, De Simone A, Bartolini M, et al
    Uleine disrupts key enzymatic and non-enzymatic biomarkers that leads to Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  129. XU DS, Ponce F
    Deep Brain Stimulation for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  130. ZORZETTO M, Datturi F, Divizia L, Pistono C, et al
    Complement C4A and C4B gene copy number study in Alzheimer's disease patients.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  131. ARCE-VARAS N, Abate G, Prandelli C, Martinez C, et al
    Comparison of extracellular and intracellular blood compartments highlights redox alterations in Alzheimer's and Mild Cognitive Impairment patients.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  132. BOUTAJANGOUT A, Noorwali A, Atta H, Wisniewski T, et al
    Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    September 2016
  133. DECOURT B, Lahiri DK, Sabbagh MN
    Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  134. HSU D, Marshall GA
    Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  135. KAMKWALALA AR, Newhouse PA
    Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  136. GONSALVEZ I, Baror R, Fried P, Santarnecchi E, et al
    Therapeutic Noninvasive Brain Stimulation in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    August 2016

  137. Erratum: Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:1198.
    PubMed     Text format     Abstract available


    June 2016
  138. HEYMANN D, Stern Y, Cosentino S, Tatarina-Nulman O, et al
    The Association Between Alcohol Use and the Progression of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  139. DI DOMENICO F, Pupo G, Giraldo E, Lloret A, et al
    Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage.
    Curr Alzheimer Res. 2016;13:112-22.
    PubMed     Text format     Abstract available


  140. CUI YQ, Wang Q, Zhang DM, Wang JY, et al
    Triptolide Rescues Spatial Memory Deficits and Amyloid-beta Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.
    Curr Alzheimer Res. 2016;13:288-96.
    PubMed     Text format     Abstract available


  141. POLJAK A, Crawford JD, Smythe GA, Brodaty H, et al
    The Relationship Between Plasma Abeta Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study.
    Curr Alzheimer Res. 2016;13:243-55.
    PubMed     Text format     Abstract available


  142. RIVERA A, Vanzuli I, Arellano JJ, Butt A, et al
    Decreased Regenerative Capacity of Oligodendrocyte Progenitor Cells (NG2-Glia) in the Ageing Brain: A Vicious Cycle of Synaptic Dysfunction, Myelin Loss and Neuronal Disruption?
    Curr Alzheimer Res. 2016;13:413-8.
    PubMed     Text format     Abstract available


  143. HOGENAUER M, Brendel M, Delker A, Darr S, et al
    Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation.
    Curr Alzheimer Res. 2016;13:597-607.
    PubMed     Text format     Abstract available


  144. BRENDEL M, Reinisch V, Kalinowski E, Levin J, et al
    Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects.
    Curr Alzheimer Res. 2016;13:475-86.
    PubMed     Text format     Abstract available


  145. VASTA R, Augimeri A, Cerasa A, Nigro S, et al
    Hippocampal Subfield Atrophies in Converted and Not-Converted Mild Cognitive Impairments Patients by a Markov Random Fields Algorithm.
    Curr Alzheimer Res. 2016;13:566-74.
    PubMed     Text format     Abstract available


  146. WILKE C, Gillardon F, Deuschle C, Dubois E, et al
    Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease.
    Curr Alzheimer Res. 2016;13:654-62.
    PubMed     Text format     Abstract available


  147. IRWIN JA, Erisir A, Kwon I
    Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.
    Curr Alzheimer Res. 2016;13:663-77.
    PubMed     Text format     Abstract available


  148. MA C, Zhang Y, Li X, Chen Y, et al
    The TT allele of rs405509 synergizes with APOE epsilon4 in the impairment of cognition and its underlying default mode network in non-demented elderly.
    Curr Alzheimer Res. 2016;13:708-17.
    PubMed     Text format     Abstract available


  149. SALVATORE C, Battista P, Castiglioni I
    Frontiers for the Early Diagnosis of AD by Means of MRI Brain Imaging and Support Vector Machines.
    Curr Alzheimer Res. 2016;13:509-33.
    PubMed     Text format     Abstract available


  150. GALLIVANONE F, Della Rosa PA, Castiglioni I
    Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD.
    Curr Alzheimer Res. 2016;13:682-94.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: